Xanax pressed
€150
Xanax (alprazolam) is an FDA-approved, Schedule IV prescription benzodiazepine indicated for the acute management of generalized anxiety disorder (GAD) and panic disorder, with or without agoraphobia, in adults. Formulated for rapid oral absorption, alprazolam functions as a positive allosteric modulator of $\text{GABA}_\text{A}$ receptors to alleviate acute panic and tension under physician supervision. Available in 0.25 mg, 0.5 mg, 1 mg, and 2 mg strengths. Valid prescription required
Product Beschrijving
Xanax (alprazolam oral tablets) is an intermediate-acting triazolobenzodiazepine indicated for the acute relief of anxiety symptoms associated with generalized anxiety disorder (GAD) and the treatment of panic disorder, with or without agoraphobia. By selectively enhancing the inhibitory actions of gamma-aminobutyric acid ($\text{GABA}$) in the central nervous system, Xanax reduces neuronal excitability within the limbic system, delivering rapid clinical symptom control.
Clinical Indications & Prescribing Overview
-
Generalized Anxiety Disorder (GAD): Short-term management of acute psychological and somatic anxiety symptoms.
-
Panic Disorder: Proven clinical reduction of spontaneous panic episodes and associated anticipatory avoidance behavior.
-
Rapid Pharmacokinetics: Achieves peak plasma concentrations within 1 to 2 hours post-administration, with an average elimination half-life of ~11.2 hours in healthy adults.
Available Strengths & Formulations
-
0.25 mg: White, oval, scored tablet debossed with “XANAX 0.25”
-
0.5 mg: Peach, oval, scored tablet debossed with “XANAX 0.5”
-
1.0 mg: Blue, oval, scored tablet debossed with “XANAX 1.0”
-
2.0 mg: White, multi-scored rectangular tablet (“bar”) debossed with “XANAX” and “2”
Important Safety Information & Boxed Warnings
-
Concomitant Opioid Risk: Combined use of benzodiazepines and opioids may cause profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing for patients with inadequate alternative treatment options.
-
Abuse, Misuse, and Addiction: Xanax is a Schedule IV controlled substance that carries risks of diversion, misuse, and addiction, which can lead to overdose and life-threatening toxicity.
-
Physical Dependence and Discontinuation: Extended use can produce clinically significant physical dependence. Abrupt discontinuation or rapid dose reduction may precipitate severe withdrawal symptoms, including delirium and grand mal seizures; gradual, individualized dosage tapering is mandatory.
| size | Regular |
|---|







info@europepharmacy.eu –
Good quality.
info@europepharmacy.eu –
Best service